12.36
price down icon6.65%   -0.88
after-market Dopo l'orario di chiusura: 12.36
loading
Precedente Chiudi:
$13.24
Aprire:
$12.71
Volume 24 ore:
2.80M
Relative Volume:
1.60
Capitalizzazione di mercato:
$2.12B
Reddito:
$3.47B
Utile/perdita netta:
$668.83M
Rapporto P/E:
3.0802
EPS:
4.0127
Flusso di cassa netto:
$253.46M
1 W Prestazione:
-6.36%
1M Prestazione:
-3.51%
6M Prestazione:
-21.04%
1 anno Prestazione:
-15.20%
Intervallo 1D:
Value
$12.36
$12.84
Intervallo di 1 settimana:
Value
$12.36
$13.37
Portata 52W:
Value
$12.36
$16.89

Dr Reddys Laboratories Ltd Adr Stock (RDY) Company Profile

Name
Nome
Dr Reddys Laboratories Ltd Adr
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
27,048
Name
Cinguettio
@drreddys
Name
Prossima data di guadagno
2025-01-23
Name
Ultimi documenti SEC
Name
RDY's Discussions on Twitter

Confronta RDY con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
RDY
Dr Reddys Laboratories Ltd Adr
12.36 2.12B 3.47B 668.83M 253.46M 4.0127
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
151.73 69.57B 9.26B 2.49B 2.30B 5.47
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.72 47.40B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.89 46.06B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
13.80 15.98B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
292.46 13.58B 2.76B 1.11B 898.10M 22.77

Dr Reddys Laboratories Ltd Adr Stock (RDY) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-19 Downgrade Nomura Buy → Neutral
2024-01-11 Downgrade Jefferies Buy → Underperform
2023-08-29 Downgrade HSBC Securities Buy → Hold
2023-05-18 Downgrade Bernstein Outperform → Mkt Perform
2023-03-17 Aggiornamento BofA Securities Neutral → Buy
2023-01-30 Iniziato JP Morgan Underweight
2022-11-14 Downgrade Credit Suisse Neutral → Underperform
2022-01-03 Ripresa BofA Securities Neutral
2021-07-27 Downgrade Credit Suisse Outperform → Neutral
2021-02-02 Aggiornamento Barclays Equal Weight → Overweight
2020-09-18 Aggiornamento BofA Securities Neutral → Buy
2020-09-18 Aggiornamento Investec Sell → Hold
2020-01-28 Downgrade CLSA Buy → Outperform
2020-01-27 Downgrade CLSA Buy → Outperform
2020-01-09 Aggiornamento Citigroup Sell → Buy
2019-11-04 Downgrade BofA/Merrill Buy → Neutral
2019-09-04 Aggiornamento Credit Suisse Underperform → Outperform
2019-07-01 Aggiornamento Macquarie Neutral → Outperform
2019-06-20 Iniziato Deutsche Bank Hold
2019-06-11 Iniziato Barclays Equal Weight
2019-05-20 Downgrade Morgan Stanley Overweight → Equal-Weight
2019-02-19 Aggiornamento CLSA Outperform → Buy
2019-01-17 Downgrade Citigroup Neutral → Sell
2017-09-21 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2017-08-31 Aggiornamento CLSA Underperform → Outperform
2017-07-28 Downgrade CLSA Underperform → Sell
2016-07-27 Downgrade HSBC Securities Hold → Reduce
2016-07-27 Downgrade Jefferies Hold → Underperform
2016-02-10 Aggiornamento Credit Agricole Underperform → Buy
2015-11-10 Downgrade Citigroup Buy → Neutral
Mostra tutto

Dr Reddys Laboratories Ltd Adr Borsa (RDY) Ultime notizie

pulisher
Apr 03, 2025

Asian Equities Traded in the US as American Depositary Receipts Fall in Thursday Trading - TradingView

Apr 03, 2025
pulisher
Apr 02, 2025

Asian Equities Traded in the US as American Depositary Receipts Trending Lower in Wednesday Trading - TradingView

Apr 02, 2025
pulisher
Mar 27, 2025

American Healthcare REIT Inc (AHR) Stock: A Year of Decreases and Increases - The InvestChronicle

Mar 27, 2025
pulisher
Mar 27, 2025

Asian Equities Traded in the US as ADRs Rise in Tuesday Trading - MSN

Mar 27, 2025
pulisher
Mar 25, 2025

Asian Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading - TradingView

Mar 25, 2025
pulisher
Mar 24, 2025

Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace

Mar 24, 2025
pulisher
Mar 21, 2025

Asian Equities Traded in the US as American Depositary Receipts Lower in Friday Trading - TradingView

Mar 21, 2025
pulisher
Mar 21, 2025

Infosys, Wipro, TCS, other IT stocks fall up to 3% after Accenture Q2 results. Details here - Mint

Mar 21, 2025
pulisher
Mar 20, 2025

Infosys, Wipro ADRs drop over 3% on NYSE after Accenture hikes full-year revenue guidance to 5-7% on AI boom - Mint

Mar 20, 2025
pulisher
Mar 20, 2025

Asian Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading - TradingView

Mar 20, 2025
pulisher
Mar 19, 2025

Asian Equities Traded in the US as American Depositary Receipts Rise Slightly in Wednesday Trading - TradingView

Mar 19, 2025
pulisher
Mar 18, 2025

Asian Equities Traded in the US as American Depositary Receipts Track Sharply Lower in Tuesday Trading - TradingView

Mar 18, 2025
pulisher
Mar 17, 2025

Asian Equities Traded in the US as American Depositary Receipts Open Week Sharply Higher - TradingView

Mar 17, 2025
pulisher
Mar 13, 2025

Bioengineered Protein Drugs Market Size to Cross USD 672.7 Billion by 2034, Growing at a CAGR of 6.2% - GlobeNewswire Inc.

Mar 13, 2025
pulisher
Mar 13, 2025

Asian Equities Traded in the US as American Depositary Receipts Lower in Thursday Trading - TradingView

Mar 13, 2025
pulisher
Mar 12, 2025

Asian Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading - TradingView

Mar 12, 2025
pulisher
Mar 12, 2025

Best upcoming stock splits and reverse splits 2024 - Investorsobserver

Mar 12, 2025
pulisher
Mar 11, 2025

Asian Equities Traded in the US as American Depositary Receipts Higher in Tuesday Trading - TradingView

Mar 11, 2025
pulisher
Mar 07, 2025

Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Up 1.5% for Week - TradingView

Mar 07, 2025
pulisher
Mar 06, 2025

Is TG Therapeutics Inc (NASDAQ: TGTX) A Good Investment For New Investors Now? - Stocks Register

Mar 06, 2025
pulisher
Mar 04, 2025

Senores Pharmaceuticals Shares: Rises 7%, acquires 14 ANDAs from Dr. Reddy’s - BusinessLine

Mar 04, 2025
pulisher
Mar 01, 2025

Rhumbline Advisers Grows Position in Dr. Reddy's Laboratories Limited (NYSE:RDY) - MarketBeat

Mar 01, 2025
pulisher
Feb 27, 2025

Dr. Reddy's Laboratories Ltd. Sponsored ADR to Host Earnings Call - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 27, 2025

Stocks to watch: Bharti Airtel, Wipro, Coforge, Dr Reddy’s, Vakrangee among shares to remain in focus today - Mint

Feb 27, 2025
pulisher
Feb 25, 2025

Share Market Update – Dr Reddy Share Price Target 2025 - LDCCBank

Feb 25, 2025
pulisher
Feb 24, 2025

Asian Equities Traded in the US as American Depositary Receipts Tumble in Monday Trading - TradingView

Feb 24, 2025
pulisher
Feb 24, 2025

Alvotech heldur kynningarfund fyrir fjárfesta 27. mars 2025, eftir birtingu uppgjörs fyrir árið 2024 og fjórða ársfjórðung - GlobeNewswire Inc.

Feb 24, 2025
pulisher
Feb 22, 2025

Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Friday Trading, Up 2.2% for Week - MSN

Feb 22, 2025
pulisher
Feb 21, 2025

Its Stock Has Paid Off Big Time For Dr. Reddy’s Laboratories Ltd. ADR - SETE News

Feb 21, 2025
pulisher
Feb 20, 2025

Marshall Wace, DE Shaw, Millennium Helped Drive China ADR Surges - Mint

Feb 20, 2025
pulisher
Feb 15, 2025

Lester Murray Antman dba SimplyRich Increases Stock Position in Dr. Reddy's Laboratories Limited (NYSE:RDY) - MarketBeat

Feb 15, 2025
pulisher
Feb 14, 2025

Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Friday Trading; End Week Up 2% - TradingView

Feb 14, 2025
pulisher
Feb 13, 2025

Asian Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading - TradingView

Feb 13, 2025
pulisher
Feb 13, 2025

Indian ADRs Alert! Why Infosys, Wipro, HDFC Bank, ICICI Bank, Dr Reddy's Lab Will Be In Focus On February 13? - Goodreturns

Feb 13, 2025
pulisher
Feb 07, 2025

Taking on analysts’ expectations and winning: Dr. Reddy’s Laboratories Ltd. ADR (RDY) - SETE News

Feb 07, 2025
pulisher
Feb 07, 2025

Dr. Reddy’s Laboratories Ltd. ADR [NYSE: RDY] Sees Decrease in Stock Value - Knox Daily

Feb 07, 2025
pulisher
Feb 07, 2025

Nothing is Better Than Sociedad Quimica Y Minera de Chile S.A. ADR (SQM) stock at the moment - SETE News

Feb 07, 2025
pulisher
Feb 07, 2025

Ecolab, Inc (ECL) expanding its growth trajectory ahead - SETE News

Feb 07, 2025
pulisher
Feb 07, 2025

A look into Golar Lng (GLNG)’s deeper side - SETE News

Feb 07, 2025
pulisher
Feb 07, 2025

Altria Group Inc [NYSE: MO] Sees Increase in Stock Value - Knox Daily

Feb 07, 2025
pulisher
Feb 07, 2025

Moody’s Corp [MCO] Shares Jump Approximately 26.66% Over the Year - Knox Daily

Feb 07, 2025
pulisher
Feb 06, 2025

Understanding the 1.67% Volatility Levels of Dr. Reddy’s Laboratories Ltd. ADR’s (RDY) Stock in the Past 30 Days - The News Heater

Feb 06, 2025
pulisher
Feb 06, 2025

LLY Stock Quote Price and Forecast - CNN

Feb 06, 2025
pulisher
Feb 03, 2025

Dr. Reddy’s Faces GST Penalty, Evaluates Appeal - TipRanks

Feb 03, 2025
pulisher
Jan 27, 2025

Of 5 billionaires contesting today’s Delhi elections, 3 are from BJP: Know their net worths - Mint

Jan 27, 2025
pulisher
Jan 24, 2025

Dr Reddy's Labs shares slide 6% post Q3 results. Should you buy, sell, or hold? - The Economic Times

Jan 24, 2025
pulisher
Jan 23, 2025

Dr. Reddy’s Labs ADR earnings missed by $0.02, revenue fell short of estimates - Investing.com

Jan 23, 2025
pulisher
Jan 23, 2025

Coupang Inc (NYSE: CPNG): A Blank Check? - Stocks Register

Jan 23, 2025

Dr Reddys Laboratories Ltd Adr Azioni (RDY) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$9.15
price down icon 5.86%
$30.06
price down icon 5.05%
$90.92
price down icon 6.47%
$7.62
price down icon 6.62%
$95.65
price down icon 7.03%
$292.46
price down icon 4.85%
Capitalizzazione:     |  Volume (24 ore):